In a surprising turn of events, researchers at the University of Vermont have made a breakthrough in flu prevention. While studying how influenza viruses replicate, they discovered that different strains of the flu use distinct methods to infiltrate human cells. This finding opens the door to new preventive strategies by targeting the specific molecules these viruses rely on.

New Insights into Flu Prevention

The study, published in The Journal of Virology, revealed that by blocking these molecules, scientists could prevent the viruses from entering new cells and stop their replication. This discovery is particularly significant for common flu strains like H1N1 and H3N2, which are responsible for most flu-related illnesses.

Dr. Emily Bruce, the principal investigator, emphasized the importance of this research, stating that it paves the way for novel strategies to treat and prevent influenza infections. Despite the availability of vaccines and antivirals, there is a pressing need for more effective medications to halt the spread of the virus within the body.

Challenges and Future Research

During their investigation, the team found that a human protein called Rab11B plays a crucial role in the entry of H3N2 viruses into lung cells. When Rab11B was depleted, these viruses failed to enter the cells, while H1N1 viruses remained unaffected. This discovery challenges the previous assumption that all flu viruses enter cells using the same mechanism.

While these findings are promising, the research was conducted using isolated cells. Further studies are needed to determine the safety and effectiveness of blocking Rab11B in a live human respiratory system. The team hopes to explore whether this dependency is a fundamental property of H3N2 or unique to current flu strains.

Original reporting: Fox News (HLL/CB) — read the source article.